Parkinson's drug pump may tame brain side effects

NCT ID NCT07151378

Recruiting now Disease control Sponsor: University Hospital Tuebingen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests a treatment called Lecigon® for people with Parkinson's disease. It is a gel given through a tube into the intestine that delivers a steady dose of medication. The goal is to see if this method reduces certain behavioral and emotional side effects better than standard treatments. About 150 adults with Parkinson's will take part, and the study lasts 6 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Disruptive, Impulse Control, and Conduct Disorders Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

Centre for Neurology, Department forNeurodegenerative Disease, and Hertie-Institute forClinical Brain Research
RECRUITING

Tübingen, 72076, Germany
Charité Campus Mitte
RECRUITING

Berlin, Germany
DRK gemeinnützige Krankenhausgesellschaft mbH Saarland
RECRUITING

Saarlouis, Saarland, 66740, Germany
Knappschaft Kliniken Bottrop GmbH
NOT_YET_RECRUITING

Bottrop, Germany
Parkinson-Klinik Ortenau GmbH & Co. KG
RECRUITING

Wolfach, Germany
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
RECRUITING

Dresden, Germany
University Hospital Marburg
NOT_YET_RECRUITING

Marburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.